Search Contract Opportunities

Preclinical Pharmacokinetic and Pharmacology Evaluations of Agents Being Developed for Cancer Patients   4

ID: 75N91021R00007 • Type: Solicitation • Match:  85%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Do the documents mention an incumbent contractor?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

Posted: Jan. 13, 2021, 3:19 p.m. EST

OFFICE OF ACQUISITIONS
NATIONAL CANCER INSTITUTE

REQUEST FOR PROPOSAL NUMBER: 75N91021R00007

Amendment No.: 4

Date of Issuance: 1/13/2021

The above numbered Request For Proposal (RFP) is amended as set forth below. The hour and date specified for receipt of Offerors is unchanged.

Offerors MUST acknowledge receipt of the amendment prior to the hour and the date specified in the solicitation or as amended, by separate letter, telegram, or Electronic Mail which includes a reference to the RFP and Amendment number(s). For your convenience, the Proposal Intent Response Form is provided in SECTION J - List of Attachments of this RFP, for this purpose.

FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERORS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER.

This Amendment hereby revises this RFP to address the three items below:

1. The reference to the required Government Notice for Handling Proposal mentioned under Attachment 16 Additional Technical Proposal Instructions under TECHNICAL PROPOSAL- TABLE OF CONTENTS, GENERAL INSTRUCTIONS, SECTION 1, C. GOVERNMENT NOTICE FOR HANDLING PROPOSALS, is hereby deleted in its entirety.

2. Attachment 18 HHS SUBCONTRACTING PLAN TEMPLATE, is hereby deleted and replaced with HHS SUBCONTRACTING PLAN TEMPLATE updated on January 12, 2021, to reflect the change in the Small Business goal of 33.25%.

3. RFP Section L - INSTRUCTIONS, CONDITIONS, AND NOTICES TO OFFERORS, Section c. BUSINESS PROPOSAL INSTRUCTIONS, Section 6. Small Business Subcontracting Plan, number 11 is hereby updates the following paragraph:

HHS expects each procuring activity to establish minimum subcontracting goals for all procurements. The anticipated minimum goals for this RFP are as follows: 33.25% for Small Business; 5% for Small Disadvantaged Business; 5% for Women-Owned Small Business; 3% for HUBZone Small Business; and 3% for Veteran-Owned Small Business and Service-Disabled Veteran-Owned Small Busines

Posted: Jan. 11, 2021, 12:35 p.m. EST
Posted: Jan. 4, 2021, 1:31 p.m. EST
Posted: Dec. 16, 2020, 11:35 a.m. EST
Posted: Nov. 20, 2020, 5:22 p.m. EST

Overview

Response Deadline
Jan. 15, 2021, 4:00 p.m. EST (original: Jan. 4, 2021, 4:00 p.m. EST) Past Due
Posted
Nov. 20, 2020, 5:22 p.m. EST (updated: Jan. 13, 2021, 3:19 p.m. EST)
Set Aside
None
Place of Performance
United States
Source

Current SBA Size Standard
1000 Employees
Pricing
Multiple Types Common
Est. Level of Competition
High
Vehicle Type
Indefinite Delivery Contract
On 11/20/20 National Cancer Institute issued Solicitation 75N91021R00007 for Preclinical Pharmacokinetic and Pharmacology Evaluations of Agents Being Developed for Cancer Patients due 1/15/21. The opportunity was issued full & open with NAICS 541715 and PSC AN12.
Primary Contact
Name
Alexis Hudak   Profile
Phone
(301) 624-8753

Secondary Contact

Name
Mary Muir   Profile
Phone
(301) 624-8764

Documents

Posted documents for Solicitation 75N91021R00007

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

Opportunity Lifecycle

Procurement notices related to Solicitation 75N91021R00007

Award Notifications

Agency published notification of awards for Solicitation 75N91021R00007

IDV Awards

Indefinite delivery vehicles awarded through Solicitation 75N91021R00007

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Solicitation 75N91021R00007

Similar Active Opportunities

Open contract opportunities similar to Solicitation 75N91021R00007

Experts for Preclinical Pharmacokinetic and Pharmacology Evaluations of Agents Being Developed for Cancer Patients

Recommended experts avaliable for hire

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > NATIONAL INSTITUTES OF HEALTH > NIH National Cancer Institute
FPDS Organization Code
7529-75NC00
Source Organization Code
500024179
Last Updated
Jan. 30, 2021
Last Updated By
alexis.hudak@nih.gov
Archive Date
Jan. 30, 2021